News

ICDR rules in favor of Glenmark over Crofelemer

23-08-2012

Indian drugmaker Glenmark Pharmaceuticals saw its shares rise 2.3% to 415 rupees yesterday after the…

crofelemerGastro-intestinalsGlenmark PharmaceuticalsLegalNapo PharmaceuticalsPharmaceutical

Salix files Crofelemer NDA as spat with Napo moves to Glenmark

15-12-2011

USA-based Salix Pharmaceuticals (Nasdaq) said yesterday that it has submitted a New Drug Application…

crofelemerGastro-intestinalsGlenmark PharmaceuticalsLegalLicensingNapo PharmaceuticalsPharmaceuticalRegulationSalix Pharmaceuticals

Napo enters finder’s agreement for development of crofelemer in China

28-04-2010

San Francisco, USA-based Napo Pharmaceuticals, which focuses on the development and commercialization…

Asia-PacificcrofelemerGastro-intestinalsLicensingLuye PharmaNapo PharmaceuticalsPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top